By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS








Company News
Soligenix (SNGX) Release: FDA Grants Soligenix "Fast Track" Designation For SGX943 For The Treatment Of Melioidosis 5/31/2016 7:35:07 AM
Soligenix (SNGX) To Present At The 2016 Marcum MicroCap Conference 5/26/2016 7:11:42 AM
Soligenix (SNGX) Receives Additional NIAID Funding To Advance Development Of Heat Stable Ricin Vaccine 5/25/2016 6:36:19 AM
Soligenix (SNGX) Announces Recent Accomplishments And First Quarter 2016 Financial Results 5/12/2016 6:53:12 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of Heat Stable Ricin Vaccine 5/5/2016 6:13:47 AM
Soligenix (SNGX) Announces Issuance Of New Patents For Dusquetide 4/14/2016 6:10:23 AM
Soligenix (SNGX) Announces Publication Of Preclinical Efficacy Results With Dusquetide In Infectious Disease 3/29/2016 6:32:48 AM
Soligenix (SNGX) Announces Recent Accomplishments And Year-End 2015 Financial Results 3/24/2016 8:40:48 AM
Soligenix (SNGX) Receives Additional NIAID Funding To Advance Development Of Heat Stable Ricin Vaccine 3/17/2016 6:25:11 AM
Soligenix (SNGX) To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference 2/2/2016 9:41:23 AM
12345678910...
//-->